Los ntawm Sam Boughedda
Investing.com - Axsome Therapeutics Inc (NASDAQ: AXSM) cov khoom lag luam poob qis dua 18% Hnub Friday, kaw qis dua $ 30.
Raws li Morgan Stanley (NYSE: MS) tus kws tshuaj ntsuam Vikram Purohit, "qhov siab tshaj plaws" tuaj yeem cuam tshuam rau lub tuam txhab kev tshem tawm los ntawm lub rooj sib tham broker yav tom ntej.
Tus kws tshuaj ntsuam tau sau rau hauv ib daim ntawv tias lawv tau txais qhov hloov tshiab los ntawm Axsome kev tswj hwm txog hnub no lub siab. Qhov hloov tshiab tau lees tias lub tuam txhab tsis tuaj yeem tuaj koom lub rooj sib tham ntawm tus kheej vim muaj teeb meem teem sijhawm.
Purohit tau taw qhia rau Axsome tswj kev taw qhia txog qhov muaj peev xwm ua tau los ntawm Food and Drug Administration ntawm Daim Ntawv Thov Tshuaj Tshiab rau Kev Kho Mob Kev Nyuaj Siab AXS-05, piav qhia tias "Muab cov qib siab ntawm cov neeg ua lag luam tsom mus & pom qhov tsis paub meej txog cov catalyst no, qee cov tub ua lag luam yuav pom qhov kev tshem tawm vim li cas. kom ceev faj txog qhov muaj peev xwm hloov kho AXS-05. "
"Txawm li cas los xij, mgt tau sau tseg hauv lawv qhov hloov tshiab tias lawv yuav ua cov rooj sib tham cov neeg ua lag luam zoo thiab tau sau tseg tias lub tuam txhab tsis paub txog kev txhim kho tsis zoo ntxiv," nws sau.
"Peb mus txuas ntxiv pom qhov kev cia siab yuav los tom ntej ntawm FDA qhov kev txiav txim ntawm AXS-05 ua qhov tseem ceeb rau AXSM, thiab cia siab tias +40% -60% upside raws li xov xwm ntawm kev pom zoo lossis nkag mus rau hauv kev sib tham thiab 50% + siab los ntawm kev tshaj tawm ntawm a CRL thiab / lossis qhov tsis txaus ntxiv, "tus kws tshuaj ntsuam ntxiv.
lwm yam khoom
Axsome Shares Sink Tom Qab Tshem Tawm Lub Rooj Sib Tham Broker: Morgan Stanley
Cov neeg tsim cai lij choj Asmeskas qhib chips, Tuam Tshoj daim nqi sib tham
Illumina xaj kom them BGI chaw muag khoom $ 333 lab hauv DNA-sequencing patent rooj plaub
Tau qhov twg los: https://finance.yahoo.com/news/axsome-shares-sink-canceling-broker-161732313.html